Ikena Oncology (IKNA)
(Delayed Data from NSDQ)
$1.67 USD
-0.01 (-0.60%)
Updated Jul 24, 2024 04:00 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Ikena Oncology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -68.17 | -68.77 | -34.12 | -44.26 | NA |
Depreciation/Amortization & Depletion | -1.00 | 0.80 | 0.54 | 0.30 | NA |
Net Change from Assets/Liabilities | -21.67 | -15.14 | -33.03 | -7.77 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 11.10 | 8.99 | 6.35 | 13.90 | NA |
Net Cash From Operating Activities | -79.74 | -74.11 | -60.25 | -37.83 | NA |
Property & Equipment | -0.41 | -1.43 | -1.76 | -0.77 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 3.69 | NA |
Investments | 64.56 | -97.85 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 64.14 | -99.28 | -1.76 | 2.92 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 36.89 | 1.10 | 131.74 | 116.18 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 39.09 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Financing Activities | 75.98 | 1.10 | 131.74 | 116.18 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | 60.38 | -172.30 | 69.73 | 81.28 | NA |
Cash at Beginning of Period | 60.79 | 233.09 | 163.36 | 82.08 | NA |
Cash at End of Period | 121.17 | 60.79 | 233.09 | 163.36 | NA |
Diluted Net EPS | -1.63 | -1.90 | -1.22 | NA | NA |
Fiscal Year End for Ikena Oncology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -16.15 | -68.17 | -48.68 | -31.33 |
Depreciation/Amortization & Depletion | NA | -0.17 | -1.00 | -0.99 | -0.66 |
Net Change from Assets/Liabilities | NA | -5.27 | -21.67 | -15.29 | -10.50 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 3.29 | 11.10 | 7.03 | 4.57 |
Net Cash From Operating Activities | NA | -18.30 | -79.74 | -57.92 | -37.93 |
Property & Equipment | NA | 0.06 | -0.41 | -0.15 | -0.15 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -48.80 | 64.56 | 43.92 | 12.02 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -48.74 | 64.14 | 43.77 | 11.87 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 36.89 | 36.89 | 37.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 39.09 | 39.03 | 0.00 |
Net Cash from Financing Activities | NA | 0.00 | 75.98 | 75.92 | 37.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -67.04 | 60.38 | 61.76 | 10.95 |
Cash at Beginning of Period | NA | 121.17 | 60.79 | 60.79 | 60.79 |
Cash at End of Period | NA | 54.13 | 121.17 | 122.56 | 71.74 |
Diluted Net EPS | NA | -0.33 | -0.40 | -0.40 | -0.44 |